{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:14:12Z","timestamp":1778746452190,"version":"3.51.4"},"reference-count":73,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15597","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:06:44Z","timestamp":1776254804000},"page":"1-15","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a prognostic model using immune related genes combined with tumour mutational burden and T cell infiltration in triple\u2011negative breast cancer"],"prefix":"10.3892","volume":"31","author":[{"given":"You","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Xin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Radio\u2011oncology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Changzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Qing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Hua","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Radio\u2011oncology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yuan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Binzhou People's Hospital, Binzhou, Shandong 256601, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jining Cancer Hospital, Jining, Shandong 272004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radio\u2011oncology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Oncology, Suzhou Xiangcheng People's Hospital, Suzhou, Jiangsu 215131, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radio\u2011oncology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"key20260514105716_b1-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e70560","DOI":"10.1002\/mco2.70560","article-title":"Breast cancer: Molecular pathogenesis, targeted therapy, screening, and prevention","volume":"7","author":"Lei","year":"2026","journal-title":"MedComm (2020)"},{"key":"key20260514105716_b2-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"key20260514105716_b3-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20260514105716_b4-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"key20260514105716_b5-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/vaccines13040344","article-title":"Advancing breast cancer treatment: The role of immunotherapy and cancer vaccines in overcoming therapeutic challenges","volume":"13","author":"Palma","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"key20260514105716_b6-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11912-018-0701-2","article-title":"Checkpoint inhibitors in the treatment of breast cancer","volume":"20","author":"Lyons","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"key20260514105716_b7-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e70439","DOI":"10.1002\/cam4.70439","article-title":"Fibroblast growth factor receptor 4 promotes triple-negative breast cancer progression via regulating fatty acid metabolism through the AKT\/RYR2 signaling","volume":"13","author":"Ye","year":"2024","journal-title":"Cancer Med"},{"key":"key20260514105716_b8-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11010-024-05093-y","article-title":"CircXPO6 promotes breast cancer progression through competitively inhibiting the ubiquitination degradation of c-Myc","volume":"480","author":"Xu","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"key20260514105716_b9-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast cancer immunotherapy: Facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20260514105716_b10-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e24720","DOI":"10.4161\/onci.24720","article-title":"Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy","volume":"2","author":"Loi","year":"2013","journal-title":"Oncoimmunology"},{"key":"key20260514105716_b11-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","article-title":"Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199","volume":"32","author":"Adams","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20260514105716_b12-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/annonc\/mdt556","article-title":"Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study","volume":"25","author":"Dieci","year":"2014","journal-title":"Ann Oncol"},{"key":"key20260514105716_b13-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e985930","DOI":"10.4161\/2162402X.2014.985930","article-title":"Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)","volume":"4","author":"Adams","year":"2015","journal-title":"Oncoimmunology"},{"key":"key20260514105716_b14-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20260514105716_b15-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20260514105716_b16-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"key20260514105716_b17-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-19-0558","article-title":"Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"key20260514105716_b18-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1101\/gr.165985.113","article-title":"Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival","volume":"24","author":"Brown","year":"2014","journal-title":"Genome Res"},{"key":"key20260514105716_b19-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"key20260514105716_b20-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"key20260514105716_b21-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"key20260514105716_b22-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"key":"key20260514105716_b23-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr2234","article-title":"T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers","volume":"11","author":"Rody","year":"2009","journal-title":"Breast Cancer Res"},{"key":"key20260514105716_b24-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"djw144","DOI":"10.1093\/jnci\/djw144","article-title":"Genomic analysis of immune cell infiltrates across 11 tumor types","volume":"108","author":"Iglesia","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"key20260514105716_b25-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/CCO.0000000000000234","article-title":"Prognostic and predictive immune gene signatures in breast cancer","volume":"27","author":"Bedognetti","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"key20260514105716_b26-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol Cancer"},{"key":"key20260514105716_b27-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamaoncol.2024.3456","article-title":"Neoadjuvant immune checkpoint inhibitors plus chemotherapy in early breast cancer: A systematic review and meta-analysis","volume":"10","author":"Villacampa","year":"2024","journal-title":"JAMA Oncol"},{"key":"key20260514105716_b28-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10238-025-01892-9","article-title":"TMB as a predictive biomarker for ICI response in TNBC: Current evidence and future directions for augmented anti-tumor responses","volume":"26","author":"Das","year":"2025","journal-title":"Clin Exp Med"},{"key":"key20260514105716_b29-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"928175","DOI":"10.3389\/fgene.2022.928175","article-title":"Prognosis prediction through an integrated analysis of single-cell and bulk RNA-sequencing data in triple-negative breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"key20260514105716_b30-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e1490854","DOI":"10.1080\/2162402X.2018.1490854","article-title":"Tumor mutational burden is a determinant of immune-mediated survival in breast cancer","volume":"7","author":"Thomas","year":"2018","journal-title":"Oncoimmunology"},{"key":"key20260514105716_b31-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: Disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol Res"},{"key":"key20260514105716_b32-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13058-015-0550-y","article-title":"Gene-expression molecular subtyping of triple-negative breast cancer tumours: Importance of immune response","volume":"17","author":"J\u00e9z\u00e9quel","year":"2015","journal-title":"Breast Cancer Res"},{"key":"key20260514105716_b33-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"key20260514105716_b34-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"key20260514105716_b35-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"key20260514105716_b36-ol-31-6-15597","first-page":"290","article-title":"Breast cancer-major changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"key20260514105716_b37-ol-31-6-15597","first-page":"4244s","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"McCarty","year":"1986","journal-title":"Cancer Res"},{"key":"key20260514105716_b38-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.2147\/CMAR.S185176","article-title":"The clinical promise of immunotherapy in triple-negative breast cancer","volume":"10","author":"Vikas","year":"2018","journal-title":"Cancer Manag Res"},{"key":"key20260514105716_b39-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e0241580","DOI":"10.1371\/journal.pone.0241580","article-title":"Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study","volume":"15","author":"Halama","year":"2020","journal-title":"PLoS One"},{"key":"key20260514105716_b40-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/jnci\/djae129","article-title":"Neoadjuvant pembrolizumab plus chemotherapy\/adjuvant pembrolizumab for early-stage triple-negative breast cancer: Quality-of-life results from the randomized KEYNOTE-522 study","volume":"116","author":"Dent","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"key20260514105716_b41-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","article-title":"Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): Updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Schmid","year":"2020","journal-title":"Lancet Oncol"},{"key":"key20260514105716_b42-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","article-title":"Triple-negative breast cancer: promising prognostic biomarkers currently in development","volume":"21","author":"Sukumar","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20260514105716_b43-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20260514105716_b44-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1010428317695023","DOI":"10.1177\/1010428317695023","article-title":"Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility","volume":"39","author":"Ravelli","year":"2017","journal-title":"Tumour Biol"},{"key":"key20260514105716_b45-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12916-015-0431-3","article-title":"Relevance of tumor-infiltrating lymphocytes in breast cancer","volume":"13","author":"Dushyanthen","year":"2015","journal-title":"BMC Med"},{"key":"key20260514105716_b46-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"key20260514105716_b47-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ccell.2018.10.007","article-title":"PEGylated IL-10 (Pegilodecakin) induces systemic immune activation, CD8+ T cell invigoration and polyclonal T cell expansion in cancer patients","volume":"34","author":"Naing","year":"2018","journal-title":"Cancer Cell"},{"key":"key20260514105716_b48-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"djw192","DOI":"10.1093\/jnci\/djw192","article-title":"Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer","volume":"109","author":"Bense","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"key20260514105716_b49-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1758835920940928","DOI":"10.1177\/1758835920940928","article-title":"Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: A systematic review and meta-analysis","volume":"12","author":"Zou","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"key20260514105716_b50-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e130000","DOI":"10.1172\/jci.insight.130000","article-title":"Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients","volume":"4","author":"Egelston","year":"2019","journal-title":"JCI Insight"},{"key":"key20260514105716_b51-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41523-019-0133-7","article-title":"If we build it they will come: Targeting the immune response to breast cancer","volume":"5","author":"Gatti-Mays","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"key20260514105716_b52-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res"},{"key":"key20260514105716_b53-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"key":"key20260514105716_b54-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e67709","DOI":"10.1371\/journal.pone.0067709","article-title":"T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice","volume":"8","author":"Montes","year":"2013","journal-title":"PLoS One"},{"key":"key20260514105716_b55-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.4049\/jimmunol.1502055","article-title":"An M1-like macrophage polarization in decidual tissue during spontaneous preterm labor that is attenuated by rosiglitazone treatment","volume":"196","author":"Xu","year":"2016","journal-title":"J Immunol"},{"key":"key20260514105716_b56-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","article-title":"Stromal cells in tumor microenvironment and breast cancer","volume":"32","author":"Mao","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"key20260514105716_b57-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"key20260514105716_b58-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"R296","DOI":"10.1152\/ajpregu.00147.2019","article-title":"Exercise as an anti-inflammatory therapy for cancer cachexia: A focus on interleukin-6 regulation","volume":"318","author":"Daou","year":"2020","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key20260514105716_b59-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","article-title":"Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"28","author":"Denkert","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20260514105716_b60-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10549-015-3438-8","article-title":"Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: Relationship to tumor-infiltrating lymphocytes","volume":"151","author":"Lee","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"key20260514105716_b61-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"616469","DOI":"10.3389\/fgene.2021.616469","article-title":"Immune cell infiltration-based characterization of triple-negative breast cancer predicts prognosis and chemotherapy response markers","volume":"12","author":"Lv","year":"2021","journal-title":"Front Genet"},{"key":"key20260514105716_b62-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.15252\/emmm.202013404","article-title":"Identification of TAPBPL as a novel negative regulator of T-cell function","volume":"13","author":"Lin","year":"2021","journal-title":"EMBO Mol Med"},{"key":"key20260514105716_b63-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2147\/IJN.S127575","article-title":"Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential","volume":"12","author":"Yu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"key20260514105716_b64-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation-a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"key20260514105716_b65-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"730442","DOI":"10.3389\/fgene.2021.730442","article-title":"Identification of immune-related risk characteristics and prognostic value of immunophenotyping in TNBC","volume":"12","author":"Yi","year":"2021","journal-title":"Front Genet"},{"key":"key20260514105716_b66-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"17588359211006680","DOI":"10.1177\/17588359211006680","article-title":"Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer","volume":"13","author":"Katsuta","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"key20260514105716_b67-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.intimp.2017.03.024","article-title":"IDO1: An important immunotherapy target in cancer treatment","volume":"47","author":"Li","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"key20260514105716_b68-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy-challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"key20260514105716_b69-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3389\/fimmu.2019.02802","article-title":"A Transcriptomic immunologic signature predicts favorable outcome in neoadjuvant chemotherapy treated triple negative breast tumors","volume":"10","author":"P\u00e9rez-Pena","year":"2019","journal-title":"Front Immunol"},{"key":"key20260514105716_b70-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"key":"key20260514105716_b71-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.smim.2019.05.002","article-title":"IFN-\u03b3: A cytokine at the right time, is in the right place","volume":"43","author":"Burke","year":"2019","journal-title":"Semin Immunol"},{"key":"key20260514105716_b72-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40425-019-0499-y","article-title":"Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer","volume":"7","author":"Yeong","year":"2019","journal-title":"J Immunother Cancer"},{"key":"key20260514105716_b73-ol-31-6-15597","doi-asserted-by":"publisher","first-page":"e17216","DOI":"10.1097\/MD.0000000000017216","article-title":"Expression and clinical significance of latent-transforming growth factor beta-binding protein 2 in primary hepatocellular carcinoma","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:57:24Z","timestamp":1778745444000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":73,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,15]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15597","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}